Results 131 to 140 of about 3,289,477 (306)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Personal protective measures and settings on the risk of SARS-COV-2 community transmission: a case-control study. [PDF]

open access: yesFront Public Health, 2023
Huguet-Torres A   +5 more
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

open access: yesMolecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Effectiveness of Protective Measures and Rules in Reducing the Incidence of Injuries in Combat Sports: A Scoping Review. [PDF]

open access: yesJ Funct Morphol Kinesiol, 2023
Štyriak R   +4 more
europepmc   +1 more source

Provisional and Protective Measures

open access: yes, 2017
Provisional, including protective, measures are often of crucial importance in family cases and cross-border situations are no exception. Under the Brussels II bis Regulation, a Member State court may use one of the two possibilities to grant such ...
Vrbljanac, Danijela, Kunda, Ivana
core   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant   +11 more
wiley   +1 more source

Agrotechnical measures as plant protection measures

open access: yesGlasnik Zaštite Bilja, 2022
Agrotechnical measures by which man creates favorable conditions for the growth and development of agricultural crops can have a great impact on the development of harmful organisms. The appropriate application of agrotechnical measures can significantly reduce the need for the application of chemical plant protection measures, and in some cases even ...
openaire   +1 more source

Retail clerks international advocate.

open access: yes, 1946
Description based on: Vol. 29, no. 1 (Jan. 1922); title from cover.Some no. combined.Mode of access: Internet.Official publication of the Retail Clerks International Protective ...
Retail Clerks International Protective Association.
core  

Kinship Quarterly: Strengthening Families [PDF]

open access: yes, 2015
Quarterly newsletter related to the "Kinship Care by Child Protective Services (CPS)" program run by the Texas Department of Family and Protective Services containing departmental information and announcements, deadlines, and other information of ...
Texas. Department of Family and Protective Services.
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy